TDOC - NYSE
Teladoc Health, Inc.
$7.09
-6.0%Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
At a Glance
Live SnapshotTeladoc Health, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
Teladoc Health, Inc. Income Statement
TDOC • NYSE
| Teladoc Health, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | |||||||||||||
2.5B | 2.6B | 2.6B | 2.4B | 2B | 1.1B | 553.3M | 417.9M | 233.3M | 123.2M | 77.4M | 43.5M | 19.9M | |
GROSS PROFIT | |||||||||||||
(771.6M) | (751.3M) | (760M) | (744M) | (650.3M) | (390.8M) | (184.5M) | (128.7M) | (61.6M) | (32M) | (21M) | (9.9M) | (4.2M) | |
1.8B | 1.8B | 1.8B | 1.7B | 1.4B | 703.1M | 368.8M | 289.2M | 171.7M | 91.2M | 56.3M | 33.6M | 15.7M | |
OPERATING INCOME | |||||||||||||
(2B) | (2.8B) | (2.1B) | (15.3B) | (1.6B) | (1.2B) | (449.3M) | (360M) | (247.1M) | (153.9M) | (112.1M) | (48.7M) | (21.6M) | |
(1.1B) | (1.3B) | (1.4B) | (1.3B) | (1.1B) | (886.9M) | (339.1M) | (265.2M) | (180.3M) | (113.6M) | (89.3M) | (38.2M) | (17.1M) | |
(277.9M) | (307.3M) | (348.5M) | (333.6M) | (311.9M) | (164.9M) | (64.6M) | (54.4M) | (34.5M) | (21.8M) | (14.2M) | (7.6M) | (3.5M) | |
-263M | -1B | -248.6M | -13.7B | -265.6M | -506.4M | -80.4M | -70.9M | -75.4M | -62.7M | -55.8M | -15.2M | -5.9M | |
PRE-TAX INCOME | |||||||||||||
(19.7M) | (23.8M) | (22.3M) | (21.9M) | (81.1M) | (60M) | (29.4M) | (26.1M) | (17.5M) | (2.6M) | (2.2M) | (1.5M) | (56K) | |
17.1M | 33.3M | 24.5M | -9.3M | -80.4M | -60M | -29.4M | -26.1M | -17.5M | -2.6M | -2.2M | -1.5M | -56K | |
(658.2M) | (1.2B) | (375.1M) | (13.7B) | (230.9M) | (157.7M) | (45.6M) | (40.5M) | (32.3M) | (18.4M) | (8.6M) | (2.9M) | (954K) | |
27.4M | 27.2M | 28.9M | -10.1M | -119M | -69.6M | -29M | -26.1M | -31.6M | -11M | -2.2M | -1.5M | -56K | |
-235.5M | -993.7M | -219.6M | -13.7B | -384.7M | -576M | -109.5M | -97M | -107M | -73.7M | -58M | -16.6M | -5.9M | |
NET INCOME | |||||||||||||
-35.2M | (7.6M) | (760K) | -3.8M | (44.1M) | -90.9M | -10.6M | (118K) | -225K | (510K) | (36K) | (388K) | (94K) | |
-200.3M | -1B | -220.4M | -13.7B | -428.8M | -485.1M | -98.9M | -97.1M | -106.8M | -74.2M | -58M | -17M | -6M |
SEC Filings
TDOC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 21, 2026 | May 21, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 30, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 29, 2026 | April 29, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 07, 2026 | May 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 30, 2026 | March 30, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 26, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 25, 2026 | February 25, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 18, 2026 | February 18, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 12, 2026 | February 08, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 16, 2025 | December 11, 2025 | 2025 |
Related Guides
Continue your TDOC research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.